Similarly, G9a enhances myoblast proliferation by enhancing E2F1 target gene expression and is upregulated in many cancers (Rao et al., 2016; Chae et al., 2019; Segovia et al., 2019; Pal et al., 2020; Souza et al., 2021). This evidence concerns the gene EHMT2 and cancer.